Peroxisome proliferator-activated receptor-γ coactivator-1α in muscle links metabolism to inflammation

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 12, 2009, Pages 1139-1143

  Handschin, Christoph ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Exercise; Inflammation; Metabolism; Muscle; Peroxisome proliferator activated receptor coactivator 1 (PGC 1 )

Indexed keywords

INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; CELL DAMAGE; CYTOKINE RELEASE; HUMAN; INFLAMMATION; MUSCLE; MUSCLE CELL; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PLASTICITY; REVIEW; SITTING; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; METABOLISM; MODELS, BIOLOGICAL; MOTOR ACTIVITY; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOSITIS; OBESITY; TRANSCRIPTION FACTORS;

EID: 72149099919     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05275.x     Document Type: Review

References (66)

1. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J. Clin. Invest. 2005 115 : 1111 1119.
2. Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008 8 : 923 934.
3. Romanyukha AA, Rudnev SG, Sidorov IA. Energy cost of infection burden. An approach to understanding the dynamics of host-pathogen interactions. J. Theor. Biol. 2006 241 : 1 13.
4. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006 444 : 860 867.
5. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003 290 : 1884 1890.
6. Hossain P, Kawar B, El NahasM. Obesity and diabetes in the developing world: A growing challenge. N. Engl. J. Med. 2007 356 : 213 215.
7. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007 132 : 2169 2180.
8. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: Tracking obesity to its source. Cell 2007 131 : 242 256.
9. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu. Rev. Pathol. 2007 2 : 31 56.
10. Trujillo ME, Scherer PE. Adipose tissue-derived factors: Impact on health and disease. Endocr. Rev. 2006 27 : 762 778.
11. Tilg H, Moschen AR. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 2006 6 : 772 783.
12. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 1993 259 : 87 91.
13. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006 580 : 2917 2921.
14. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNFα by human muscle. Relationship to insulin resistance. J. Clin. Invest. 1996 97 : 1111 1116.
15. Bouzakri K, Koistinen HA, Zierath JR. Molecular mechanisms of skeletal muscle insulin resistance in Type 2 diabetes. Curr. Diab. Rev. 2005 1 : 167 174.
16. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol. Rev. 2006 86 : 205 243.
17. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE. Waging war on physical inactivity: Using modern molecular ammunition against an ancient enemy. J. Appl. Physiol. 2002 93 : 3 30.
18. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N. Engl. J. Med. 2004 351 : 2694 2703.
19. Knowler WC, Barrett-Connor E, Fowler SE et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002 346 : 393 403.
20. Pedersen BK, Akerstrom TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J. Appl. Physiol. 2007 103 : 1093 1098.
21. Febbraio MA, Pedersen BK. Contraction-induced myokine production and release: Is skeletal muscle an endocrine organ? Exerc. Sport Sci. Rev. 2005 33 : 114 119.
22. Carey AL, Febbraio MA. Interleukin-6 and insulin sensitivity: Friend or foe? Diabetologia 2004 47 : 1135 1142.
23. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: The good, the bad, or the indifferent? Diabetes 2005 54 (Suppl. 2 S114 24.
24. Pedersen BK, Steensberg A, Fischer C et al. Searching for the exercise factor: Is IL-6 a candidate? J. Muscle Res. Cell 2003 24 : 113 119.
25. Febbraio MA. Exercise and inflammation. J. Appl. Physiol. 2007 103 : 376 377.
26. Gleeson M. Immune function in sport and exercise. J. Appl. Physiol. 2007 103 : 693 699.
27. Flück M, Hoppeler H. Molecular basis of skeletal muscle plasticity: From gene to form and function. Rev. Physiol. Biochem. Pharmacol. 2003 146 : 159 216.
28. Berchtold MW, Brinkmeier H, Muntener M. Calcium ion in skeletal muscle. Its crucial role for muscle function, plasticity, and disease. Physiol. Rev. 2000 80 : 1215 1265.
29. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM. An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle. Proc. Natl Acad. Sci. USA 2003 100 : 7111 7116.
30. Czubryt MP, McAnally J, Fishman GI, Olson EN. Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5. Proc. Natl Acad. Sci. USA 2003 100 : 1711 1716.
31. Jager S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1a. Proc. Natl Acad. Sci. USA 2007 104 : 12017 12022.
32. Richter EA, Ruderman NB. AMPK and the biochemistry of exercise. Implications for human health and disease. Biochem. J. 2009 418 : 261 275.
33. Gerhart-Hines Z, Rodgers JT, Bare O et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α. EMBO J. 2007 26 : 1913 1923.
34. Freyssenet D. Energy sensing and regulation of gene expression in skeletal muscle. J. Appl. Physiol. 2007 102 : 529 540.
35. Rodgers JT, Lerin C, Gerhart-Hines Z, Puigserver P. Metabolic adaptations through the PGC-1α and SIRT1 pathways. FEBS Lett. 2008 582 : 46 53.
36. Puigserver P, Rhee J, Lin J et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARγ coactivator-1. Mol. Cell 2001 8 : 971 982.
37. Nisoli E, Clementi E, Paolucci C et al. Mitochondrial biogenesis in mammals: The role of endogenous nitric oxide. Science 2003 299 : 896 899.
38. Miura S, Kawanaka K, Kai Y et al. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated by β-adrenergic receptor activation. Endocrinology 2007 148 : 3441 3448.
39. Pearen MA, Ryall JG, Maxwell MA, Ohkura N, Lynch GS, Muscat GE. The orphan nuclear receptor, NOR-1, is a target of β-adrenergic signaling in skeletal muscle. Endocrinology 2006 147 : 5217 5227.
40. Chao LC, Zhang Z, Pei L, Saito T, Tontonoz P, Pilch PF. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol. Endocrinol. 2007 21 : 2152 2163.
41. Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, Spiegelman BM. PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 2007 21 : 770 783.
42. Gardiner P, Dai Y, Heckman CJ. Effects of exercise training on α-motoneurons. J. Appl. Physiol. 2006 101 : 1228 1236.
43. Kummer TT, Misgeld T, Sanes JR. Assembly of the postsynaptic membrane at the neuromuscular junction: Paradigm lost. Curr. Opin. Neurobiol. 2006 16 : 74 82.
44. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005 1 : 361 370.
45. Handschin C, Spiegelman BM. PGC-1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 2006 27 : 728 735.
46. St-Pierre J, Lin J, Krauss S et al. Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J. Biol. Chem. 2003 278 : 26597 26603.
47. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor α in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 2000 20 : 1868 1876.
48. Mootha VK, Handschin C, Arlow D et al. Errα and Gabpa/b specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl Acad. Sci. USA 2004 101 : 6570 6575.
49. Benton CR, Nickerson JG, Lally J et al. Modest PGC-1α overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria. J. Biol. Chem. 2008 283 : 4228 4240.
50. Lin J, Wu H, Tarr PT et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 2002 418 : 797 801.
51. Sandri M, Lin J, Handschin C et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl Acad. Sci. USA 2006 103 : 16260 16265.
52. Wende AR, Schaeffer PJ, Parker GJ et al. A role for the transcriptional coactivator PGC-1α in muscle refueling. J. Biol. Chem. 2007 282 : 36642 36651.
53. Hanai JI, Cao P, Tanksale P et al. The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity. J. Clin. Invest. 2007 117 : 3940 3951.
54. Wenz T, Diaz F, Spiegelman BM, Moraes CT. Activation of the PPAR/PGC-1α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 2008 8 : 249 256.
55. Russell AP, Feilchenfeldt J, Schreiber S et al. Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-γ coactivator-1 and peroxisome proliferator-activated receptor-α in skeletal muscle. Diabetes 2003 52 : 2874 2881.
56. Pilegaard H, Saltin B, Neufer PD. Exercise induces transient transcriptional activation of the PGC-1α gene in human skeletal muscle. J. Physiol. 2003 546 : 851 858.
57. Mootha VK, Lindgren CM, Eriksson KF et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003 34 : 267 273.
58. Patti ME, Butte AJ, Crunkhorn S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 2003 100 : 8466 8471.
59. Handschin C, Chin S, Li P et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem. 2007 282 : 30014 30021.
60. Handschin C, Choi CS, Chin S et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1α knockout mice reveals skeletal muscle-pancreatic β cell crosstalk. J. Clin. Invest. 2007 117 : 3463 3474.
61. Handschin C, Spiegelman BM. The role of exercise and PGC1α in inflammation and chronic disease. Nature 2008 454 : 463 469.
62. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 2005 98 : 911 917.
63. Cai D, Frantz JD, Tawa NE Jr. et al. IKKb/NF-κB activation causes severe muscle wasting in mice. Cell 2004 119 : 285 298.
64. Coletti D, Moresi V, Adamo S, Molinaro M, Sassoon D. Tumor necrosis factor-α gene transfer induces cachexia and inhibits muscle regeneration. Genesis 2005 43 : 120 128.
65. Arany Z, Wagner BK, Ma Y, Chinsomboon J, Laznik D, Spiegelman BM. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1α and oxidative phosphorylation. Proc. Natl Acad. Sci. USA 2008 105 : 4721 4726.
66. Wagner BK, Kitami T, Gilbert TJ et al. Large-scale chemical dissection of mitochondrial function. Nat. Biotechnol. 2008 26 : 343 351.